Home » Topics » Regulatory » Patents

Patents
RSS

Fibrinogen antagonists from DuPont Merck

July 19, 1996

Fibrinogen antagonists from Merck & Co.

July 19, 1996

BASF reveals thrombin inhibitor as thrombosis/arterial reocclusion therapy

July 19, 1996

FO-2047: Kitasato Institute's lipid peroxidation inhibitor

July 19, 1996

LDL oxidation inhibitors as arteriosclerosis/myocardial ischemia treatment from Chugai

July 19, 1996

Benzofuran smooth muscle proliferation inhibitors from Lilly

July 19, 1996

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...